Module 3 2019

Conclusions ➢ CMC is not the poor relation in medicines development and cannot be left to last ➢ CMC data needs change constantly throughout development and during product life cycle ➢ In the long term well understood and reproducible quality is the best protection against product quality failure or supply issues in the market

But it is not infallible

29